Endometrial Mixed Adenocarcinoma

specific

An adenocarcinoma that arises from the endometrium and is characterized by the presence of both type I and type II endometrial adenocarcinoma components. The minor component constitutes at least 5% of the entire tumor.

Centers

Active Trials

—

Cancer Funding

Top Centers for Endometrial Mixed Adenocarcinoma(13)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	—	—	53.8
2	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive	—	—	53.8
3	Duke Cancer InstituteDurham, NC NCI Comprehensive	—	—	53.8
4	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	—	—	53.8
5	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	53.8
6	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive	—	—	53.8
7	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	—	53.8
8	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	53.8
9	Cleveland Clinic Cancer CenterCleveland, OH	—	—	53.8
10	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive	—	—	53.8
11	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical	—	—	53.8
12	University of Illinois Cancer CenterChicago, IL	—	—	53.8
13	Cancer Center at IllinoisUrbana, IL	—	—	53.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →